No connection

Search Results

BLX

NEUTRAL
$46.76 Live
Banco Latinoamericano de Comercio Exterior, S. A. · NYSE
Target $55.5 (+18.7%)
$31.14 52W Range $48.38

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Jan 24, 2026
Market cap
$1.72B
P/E
7.9
ROE
15.0%
Profit margin
72.1%
Debt/Equity
N/A
Dividend yield
5.27%

AI Analysis

AI-powered fundamental assessment

Confidence
65%
The stock exhibits weak financial health with a Piotroski F-Score of just 2/9, signaling significant fundamental concerns. Despite this, BLX trades at a discount to both Graham Number ($76.75) and intrinsic value ($63.64), supported by a low P/E of 7.90 and strong profitability margins above 72%. Recent earnings growth is exceptionally strong (YoY EPS +88.9%), but inconsistent historical earnings surprises and poor technical trend (10/100) offset optimism. The 5.27% dividend yield and low payout ratio add appeal, though insider sentiment is weak and analyst coverage is sparse.

Key Strengths

High profitability with operating margin of 72.51% and net margin of 72.10%
Attractive valuation: P/E of 7.90 well below sector average of 30.45
Strong dividend yield of 5.27% with sustainable 39.58% payout ratio
Significant recent earnings growth: YoY EPS +88.9%, Q/Q EPS +82.1%
Stock trades below both Graham Number ($76.75) and intrinsic value ($63.64)

Key Risks

Very weak Piotroski F-Score of 2/9 indicates poor financial health and potential distress risk
Missing Altman Z-Score prevents distress risk confirmation, but low F-Score raises red flags
Poor technical trend (10/100) suggests ongoing bearish momentum
Low insider sentiment (40/100) implies lack of confidence from company insiders
Sparse analyst coverage (only 2 analysts) and no consensus recommendation reduce visibility
AI Fair Value Estimate
Based on comprehensive analysis
$63.64
+36.1% above current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
64
Strong
Value
85
Future
75
Past
50
Health
30
Dividend
80
AI Verdict
Neutral with value and growth offsets to financial health risks
Key drivers: Low Piotroski F-Score, Strong recent EPS growth, High dividend yield, Valuation discount to Graham and intrinsic value, Bearish technical trend
Confidence
70%
Value
85/100

Ref P/E, PEG, Graham Number

Positives
  • P/E of 7.90 significantly below sector average of 30.45
  • Price/Book of 1.06 suggests near-book valuation
  • Current price ($46.76) below Graham Number ($76.75) and intrinsic value ($63.64)
Watchpoints
No urgent risks highlighted.
Future
75/100

Ref Growth rates

Positives
  • Year-over-year EPS growth of +88.9%
  • Q/Q EPS growth of +82.1%
  • Revenue growth stable at 3.10% YoY
Watchpoints
  • Forward P/E not significantly lower than current P/E, suggesting tempered expectations
  • PEG Ratio not available, limiting growth-adjusted valuation insight
Past
50/100

Ref Historical trends

Positives
  • 5-year price return of +299.4% shows strong long-term capital appreciation
  • Only 1 earnings beat in last 4 quarters, but recent quarters show improvement
Watchpoints
  • Highly inconsistent earnings surprises historically (e.g., -290.7% in 2018)
  • Frequent earnings misses over the past 5 years
Health
30/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • ROE of 15.04% is above cost of equity and sector average (avg ROE: -9.78%)
Watchpoints
  • Piotroski F-Score of 2/9 indicates severe financial weakness
  • Missing key health metrics: Debt/Equity, Current Ratio, Altman Z-Score
  • ROA of only 1.86% suggests inefficient asset use despite high ROE
Dividend
80/100

Ref Yield, Payout

Positives
  • Dividend yield of 5.27% is high and attractive in current rate environment
  • Payout ratio of 39.58% is sustainable and leaves room for growth
  • Dividend Strength score of 70/100 indicates reliable payout history
Watchpoints
No urgent risks highlighted.

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$46.76
Analyst Target
$55.5
Upside/Downside
+18.7%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for BLX and closest competitors.

Updated 2026-01-23
BLX
Banco Latinoamericano de Comercio Exterior, S. A.
Primary
5Y
+299.4%
3Y
+227.1%
1Y
+29.8%
6M
+12.0%
1M
+5.6%
1W
+3.8%
EZP
EZCORP, Inc.
Peer
5Y
+422.0%
3Y
+218.9%
1Y
+83.8%
6M
+47.9%
1M
+5.0%
1W
+7.7%
GAB
The Gabelli Equity Trust Inc.
Peer
5Y
+36.2%
3Y
+37.8%
1Y
+17.0%
6M
-1.7%
1M
+0.7%
1W
-3.1%
ETV
Eaton Vance Tax-Managed Buy-Write Opportunities Fund
Peer
5Y
+40.1%
3Y
+54.6%
1Y
+23.8%
6M
+4.9%
1M
+4.2%
1W
-0.8%
BDJ
BlackRock Enhanced Equity Dividend Trust
Peer
5Y
+74.8%
3Y
+37.0%
1Y
+19.0%
6M
+12.5%
1M
+2.6%
1W
+0.9%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
7.9
Forward P/E
7.23
PEG Ratio
N/A
P/B Ratio
1.06
P/S Ratio
5.59
EV/Revenue
16.82
EV/EBITDA
N/A
Market Cap
$1.72B

Profitability

Profit margins and return metrics

Profit Margin 72.1%
Operating Margin 72.51%
Gross Margin N/A
ROE 15.04%
ROA 1.86%

Growth

Revenue and earnings growth rates

Revenue Growth +3.1%
Earnings Growth +2.5%
Q/Q Revenue Growth N/A
Q/Q Earnings Growth +3.7%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
N/A
Current Ratio
N/A
Quick Ratio
N/A
Cash/Share
$4.46

Quarterly Earnings History

EPS performance vs analyst estimates

2026-02-26
$N/A
2023-07-20
$1.02
+12.0% surprise
2020-02-14
$0.56
2019-10-18
$0.52
-8.8% surprise

Financial Services Sector Comparison

Comparing BLX against 820 companies in the Financial Services sector (141 bullish, 351 neutral, 328 bearish)
P/E Ratio
7.9
This Stock
vs
36.01
Sector Avg
-78.1% (Discount)
Return on Equity (ROE)
15.04%
This Stock
vs
-0.73%
Sector Avg
-2153.1% (Below Avg)
Profit Margin
72.1%
This Stock
vs
91.62%
Sector Avg
-21.3% (Weaker)
Revenue Growth
3.1%
This Stock
vs
35.27%
Sector Avg
-91.2% (Slower)

Similar Companies

Peer comparison within the same industry

Past News Coverage

Recent headlines mentioning BLX from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile